130 related articles for article (PubMed ID: 11956663)
21. Shc family expression in neuroblastoma: high expression of shcC is associated with a poor prognosis in advanced neuroblastoma.
Terui E; Matsunaga T; Yoshida H; Kouchi K; Kuroda H; Hishiki T; Saito T; Yamada S; Shirasawa H; Ohnuma N
Clin Cancer Res; 2005 May; 11(9):3280-7. PubMed ID: 15867224
[TBL] [Abstract][Full Text] [Related]
22. c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.
Vitali R; Cesi V; Nicotra MR; McDowell HP; Donfrancesco A; Mannarino O; Natali PG; Raschellà G; Dominici C
Int J Cancer; 2003 Aug; 106(2):147-52. PubMed ID: 12800187
[TBL] [Abstract][Full Text] [Related]
23. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM
Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915
[TBL] [Abstract][Full Text] [Related]
24. Panax ginseng increases hypoxia-induced down-regulated cellular response related genes in human neuroblastoma cells, SK-N-MC.
Park H; Kim H; Ha E; Yoon S; Kim MJ; Hong M; Leem KH; Hong SJ; Yang J; Chung JH
Neurol Res; 2007; 29 Suppl 1():S78-87. PubMed ID: 17359646
[TBL] [Abstract][Full Text] [Related]
25. Gene expression of TRK neurotrophin receptors in advanced neuroblastomas in Singapore--a pilot study.
Fung W; Hasan MY; Loh AH; Chua JH; Yong MH; Knight L; Hwang WS; Chan MY; Seow WT; Jacobsen AS; Chui CH
Pediatr Hematol Oncol; 2011 Oct; 28(7):571-8. PubMed ID: 21728718
[TBL] [Abstract][Full Text] [Related]
26. Expression of SMARCF1, a truncated form of SWI1, in neuroblastoma.
Takeuchi T; Nicole S; Misaki A; Furihata M; Iwata J; Sonobe H; Ohtsuki Y
Am J Pathol; 2001 Feb; 158(2):663-72. PubMed ID: 11159203
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma.
de Souza DR; Sanabani SS; de Souza AC; Filho Odone V; Epelman S; Bendit I
Pediatr Blood Cancer; 2011 May; 56(5):749-56. PubMed ID: 21154590
[TBL] [Abstract][Full Text] [Related]
28. The high level of hCDC10 gene expression in neuroblastoma may be associated with favorable characteristics of the tumor.
Nagata T; Takahashi Y; Asai S; Ishii Y; Mugishima H; Suzuki T; Chin M; Harada K; Koshinaga S; Ishikawa K
J Surg Res; 2000 Aug; 92(2):267-75. PubMed ID: 10896833
[TBL] [Abstract][Full Text] [Related]
29. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Hu YC; Lam KY; Law S; Wong J; Srivastava G
Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
[TBL] [Abstract][Full Text] [Related]
30. MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors.
Grau E; Oltra S; Martínez F; Orellana C; Cañete A; Fernández JM; Hernández-Martí M; Castel V
J Cancer Res Clin Oncol; 2009 Apr; 135(4):523-31. PubMed ID: 18820946
[TBL] [Abstract][Full Text] [Related]
31. Identification of genes that are regulated transcriptionally by Myc in childhood tumors.
Raetz EA; Kim MK; Moos P; Carlson M; Bruggers C; Hooper DK; Foot L; Liu T; Seeger R; Carroll WL
Cancer; 2003 Aug; 98(4):841-53. PubMed ID: 12910530
[TBL] [Abstract][Full Text] [Related]
32. Differential gene expression profiles between neuroblastomas with high telomerase activity and low telomerase activity.
Hiyama E; Hiyama K; Nishiyama M; Reynolds CP; Shay JW; Yokoyama T
J Pediatr Surg; 2003 Dec; 38(12):1730-4. PubMed ID: 14666454
[TBL] [Abstract][Full Text] [Related]
33. IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma.
Bell JL; Turlapati R; Liu T; Schulte JH; Hüttelmaier S
J Clin Oncol; 2015 Apr; 33(11):1285-93. PubMed ID: 25753434
[TBL] [Abstract][Full Text] [Related]
34. Variations in gene expression patterns correlated with phenotype of F-11 tumor cells whose expression of GD3-synthase is suppressed.
Zeng G; Gao L; Suetake K; Joshi RM; Yu RK
Cancer Lett; 2002 Apr; 178(1):91-8. PubMed ID: 11849746
[TBL] [Abstract][Full Text] [Related]
35. Dickkopf-1 is down-regulated by MYCN and inhibits neuroblastoma cell proliferation.
Koppen A; Ait-Aissa R; Hopman S; Koster J; Haneveld F; Versteeg R; Valentijn LJ
Cancer Lett; 2007 Oct; 256(2):218-28. PubMed ID: 17643814
[TBL] [Abstract][Full Text] [Related]
36. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
Chakrabarti R; Robles LD; Gibson J; Muroski M
Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
[TBL] [Abstract][Full Text] [Related]
37. A three-gene expression signature model for risk stratification of patients with neuroblastoma.
Garcia I; Mayol G; Ríos J; Domenech G; Cheung NK; Oberthuer A; Fischer M; Maris JM; Brodeur GM; Hero B; Rodríguez E; Suñol M; Galvan P; de Torres C; Mora J; Lavarino C
Clin Cancer Res; 2012 Apr; 18(7):2012-23. PubMed ID: 22328561
[TBL] [Abstract][Full Text] [Related]
38. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC.
Hu YC; Lam KY; Law S; Wong J; Srivastava G
Clin Cancer Res; 2001 Aug; 7(8):2213-21. PubMed ID: 11489794
[TBL] [Abstract][Full Text] [Related]
39. Expression of the prothymosin alpha mRNA correlated with that of N-myc in neuroblastoma.
Sasaki H; Sato Y; Kondo S; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y
Cancer Lett; 2001 Jul; 168(2):191-5. PubMed ID: 11403924
[TBL] [Abstract][Full Text] [Related]
40. Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray.
Wang L; Zhu JS; Song MQ; Chen GQ; Chen JL
World J Gastroenterol; 2006 Nov; 12(43):6949-54. PubMed ID: 17109515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
